Omega Healthcare Investors (OHI) FY2019 results: revenue $929 million, up 5.3% on the year
Omega Healthcare Investors Inc. (OHI) reported revenue of $929 million for fiscal 2019, the year ended 31 December 2019, up 5.3% on the year before. Net income was $341 million, up 21.1%, and diluted earnings per share $1.58. The figures are the company's own, from the 10-K it filed with the SEC on 28 February 2020.
Revenue
$929 million
+5.3% on the year
FY2012FY2019
Operating margin
59.4%
56.4% a year earlier
FY2012FY2019
Net income
$341 million
+21.1% on the year
FY2012FY2019
Diluted EPS
$1.58
+12.9% on the year
FY2012FY2019
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Revenue
929
882
908
+5.3%
Operating income
552
498
315
+10.9%
Operating margin
59.4%
56.4%
34.7%
Interest expense
209
192
189
+8.4%
Pre-tax income
344
297
106
+16.0%
Income tax
2.8
3.0
3.2
-5.5%
Effective tax rate
0.8%
1.0%
3.1%
Net income
341
282
100
+21.1%
Net margin
36.7%
31.9%
11.1%
Diluted EPS
$1.58
$1.40
$0.51
+12.9%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Operating cash flow
554
499
578
+10.9%
Capital expenditure
52.9
29.8
37.8
+77.3%
Free cash flow
501
470
540
+6.7%
Free cash flow margin
53.9%
53.3%
59.5%
Cash from investing
-379
-173
-285
Cash from financing
-154
-411
-304
Depreciation and amortisation
302
281
288
+7.3%
Share-based compensation
15.4
16.0
15.2
-3.9%
Dividends paid
564
529
503
+6.7%
Dividend per share
$2.65
$2.64
$2.54
+0.4%
Diluted shares, weighted
222m
210m
207m
+5.9%
Shares outstanding at period end
227m
202m
198m
+12.0%
Balance sheet
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Shareholders' equity
4,135
3,444
3,555
+20.1%
Non-controlling interest
201
320
333
-37.1%
Debt
5,136
4,541
4,572
+13.1%
Other liabilities
323
286
313
+13.2%
Total liabilities and equity
9,796
8,591
8,773
+14.0%
Goodwill
644
644
645
+0.1%
Intangible assets
28.0
n/a
n/a
Cash and equivalents
24.1
10.3
85.9
+134.1%
Other assets
9,100
7,937
8,043
+14.7%
Total assets
9,796
8,591
8,773
+14.0%
10-K for the year ended 31 December 2019, filed 28 February 2020: the filing.